Valentine Laura E, Loffredo John T, Bean Alex T, León Enrique J, MacNair Caitlin E, Beal Dominic R, Piaskowski Shari M, Klimentidis Yann C, Lank Simon M, Wiseman Roger W, Weinfurter Jason T, May Gemma E, Rakasz Eva G, Wilson Nancy A, Friedrich Thomas C, O'Connor David H, Allison David B, Watkins David I
Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
J Virol. 2009 Nov;83(22):11514-27. doi: 10.1128/JVI.01298-09. Epub 2009 Sep 2.
An understanding of the mechanism(s) by which some individuals spontaneously control human immunodeficiency virus (HIV)/simian immunodeficiency virus replication may aid vaccine design. Approximately 50% of Indian rhesus macaques that express the major histocompatibility complex (MHC) class I allele Mamu-B08 become elite controllers after infection with simian immunodeficiency virus SIVmac239. Mamu-B08 has a binding motif that is very similar to that of HLA-B27, a human MHC class I allele associated with the elite control of HIV, suggesting that SIVmac239-infected Mamu-B08-positive (Mamu-B08+) animals may be a good model for the elite control of HIV. The association with MHC class I alleles implicates CD8+ T cells and/or natural killer cells in the control of viral replication. We therefore introduced point mutations into eight Mamu-B08-restricted CD8+ T-cell epitopes to investigate the contribution of epitope-specific CD8+ T-cell responses to the development of the control of viral replication. Ten Mamu-B08+ macaques were infected with this mutant virus, 8X-SIVmac239. We compared immune responses and viral loads of these animals to those of wild-type SIVmac239-infected Mamu-B08+ macaques. The five most immunodominant Mamu-B08-restricted CD8+ T-cell responses were barely detectable in 8X-SIVmac239-infected animals. By 48 weeks postinfection, 2 of 10 8X-SIVmac239-infected Mamu-B08+ animals controlled viral replication to <20,000 viral RNA (vRNA) copy equivalents (eq)/ml plasma, while 10 of 15 wild-type-infected Mamu-B08+ animals had viral loads of <20,000 vRNA copy eq/ml (P = 0.04). Our results suggest that these epitope-specific CD8+ T-cell responses may play a role in establishing the control of viral replication in Mamu-B*08+ macaques.
了解某些个体自发控制人类免疫缺陷病毒(HIV)/猴免疫缺陷病毒复制的机制可能有助于疫苗设计。表达主要组织相容性复合体(MHC)I类等位基因Mamu - B08的印度恒河猴中,约50%在感染猴免疫缺陷病毒SIVmac239后成为精英控制者。Mamu - B08具有一个与HLA - B27非常相似的结合基序,HLA - B27是一种与HIV精英控制相关的人类MHC I类等位基因,这表明感染SIVmac239的Mamu - B08阳性(Mamu - B08+)动物可能是HIV精英控制的良好模型。与MHC I类等位基因的关联表明CD8+ T细胞和/或自然杀伤细胞参与了病毒复制的控制。因此,我们在八个Mamu - B08限制性CD8+ T细胞表位中引入点突变,以研究表位特异性CD8+ T细胞反应对病毒复制控制发展的贡献。十只Mamu - B08+猕猴感染了这种突变病毒8X - SIVmac239。我们将这些动物的免疫反应和病毒载量与野生型SIVmac239感染的Mamu - B08+猕猴进行了比较。在感染8X - SIVmac239的动物中,几乎检测不到五个最具免疫优势的Mamu - B08限制性CD8+ T细胞反应。感染后48周,10只感染8X - SIVmac239的Mamu - B08+动物中有2只将病毒复制控制在血浆中病毒RNA(vRNA)拷贝当量(eq)/毫升<20,000,而15只野生型感染的Mamu - B08+动物中有10只病毒载量<20,000 vRNA拷贝eq/毫升(P = 0.04)。我们的结果表明,这些表位特异性CD8+ T细胞反应可能在建立Mamu - B*08+猕猴的病毒复制控制中发挥作用。